Search results
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 5 days agoPfizer’s PFE phase III study of investigational gene therapy, fordadistrogene movaparvovec, for...
Avidity Up 33% on Rare Muscle Disease Study Results - Arcutis Biotherapeutics (NASDAQ:ARQT), Heron...
Benzinga· 5 days agoAvidity Biosciences RNA announced encouraging initial data from the phase I/II FORTITUDE study...
Pfizer’s gene-therapy trial failure boosts Sarepta’s stock
Market Watch· 6 days agogained 4% premarket on Thursday after a potential competitor to its gene therapy stumbled in a...
Pfizer setback brings questions for Duchenne gene therapy ahead of Sarepta decision
BioPharma Dive via Yahoo Finance· 6 days agoThe failure of another trial adds to uncertainty around the benefits of the gene-based treatments,...
Sarepta Jumps After Rival Gene Therapy From Pfizer Flops
Investor's Business Daily· 5 days agoThe news gives Sarepta Therapeutics (SRPT) an edge heading to June 21, when the Food and Drug Administration will decide whether to fully approve Elevidys for patients with the muscle-wasting ...
Pfizer gene therapy for Duchenne fails to meet goals of key trial
BioPharma Dive via Yahoo Finance· 6 days agoThe negative results from the Phase 3 study, called Ciffreo, come a little more than a month after...
Avidity Biosciences to Participate in Upcoming Investor Conference
KPVI· 5 days agoA live webcast of the event, up-to-date event details and an archived replay will be available on the "Events and Presentations" page in the "Investors" section of Avidity's website at https ...
Cranbury Pharmaceuticals Receives FDA Approval for First Generic Version of Emflaza Oral Suspension
New Jersey Business Magazine· 6 days agoCranbury Pharmaceuticals, a wholly-owned subsidiary of Tris Pharma, today announced the U.S. Food...
Pfizer faces setback with gene therapy acquired from North Carolina firm - Triangle Business Journal
The Business Journals· 5 days agoPfizer is facing a major clinical setback in a gene therapy program with ties to the Triangle. The...
Health Care Roundup: Market Talk
The Wall Street Journal· 6 days agoPublished exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0748 ET – The failure of Pfizer’s proposed gene therapy for Duchenne ...